New guideline for treating Allan-Herndon-Dudley syndrome

Allan-Herndon-Dudley syndrome is a rare congenital disease of thyroid metabolism.

It occurs in approximately 1 out of every 70,000 male newborns, and its effects are devastating.

Since early 2025, a medication has been approved in Europe that can alleviate symptoms and extend patients' life expectancy.

However, the dosage is complicated. ...